These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11140468)

  • 21. MHC-linked susceptibility to type 1 diabetes in the NOD mouse: further localization of Idd16 by subcongenic analysis.
    Fujisawa T; Ikegami H; Noso S; Yamaji K; Nojima K; Babaya N; Itoi-Babaya M; Hiromine Y; Kobayashi M; Makino S; Ogihara T
    Ann N Y Acad Sci; 2006 Oct; 1079():118-21. PubMed ID: 17130541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased NF-kappa B activity in B cells and bone marrow-derived dendritic cells from NOD mice.
    Wheat W; Kupfer R; Gutches DG; Rayat GR; Beilke J; Scheinman RI; Wegmann DR
    Eur J Immunol; 2004 May; 34(5):1395-404. PubMed ID: 15114673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development.
    O'Keeffe M; Brodnicki TC; Fancke B; Vremec D; Morahan G; Maraskovsky E; Steptoe R; Harrison LC; Shortman K
    Int Immunol; 2005 Mar; 17(3):307-14. PubMed ID: 15684037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of type 1 diabetes in NOD mice by bifunctional peptide inhibitor: modulation of the immunological synapse formation.
    Murray JS; Oney S; Page JE; Kratochvil-Stava A; Hu Y; Makagiansar IT; Brown JC; Kobayashi N; Siahaan TJ
    Chem Biol Drug Des; 2007 Sep; 70(3):227-36. PubMed ID: 17718717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse.
    Joussemet B; Vu AT; Sai P; Bach JM
    Ann N Y Acad Sci; 2005 Jun; 1051():613-25. PubMed ID: 16127002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
    Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
    Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8+ T cells in type 1 diabetes.
    Tsai S; Shameli A; Santamaria P
    Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse.
    Strid J; Lopes L; Marcinkiewicz J; Petrovska L; Nowak B; Chain BM; Lund T
    Clin Exp Immunol; 2001 Mar; 123(3):375-81. PubMed ID: 11298122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coxsackieviruses and diabetes.
    Ramsingh AI; Chapman N; Tracy S
    Bioessays; 1997 Sep; 19(9):793-800. PubMed ID: 9297970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innate immunity in type 1 diabetes.
    Diana J; Gahzarian L; Simoni Y; Lehuen A
    Discov Med; 2011 Jun; 11(61):513-20. PubMed ID: 21712017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NOD mouse: a model of immune dysregulation.
    Anderson MS; Bluestone JA
    Annu Rev Immunol; 2005; 23():447-85. PubMed ID: 15771578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-intrinsic effects of non-MHC NOD genes on dendritic cell generation in vivo.
    Prasad SJ; Goodnow CC
    Int Immunol; 2002 Jun; 14(6):677-84. PubMed ID: 12039919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The NOD mouse model of type 1 diabetes: as good as it gets?
    Atkinson MA; Leiter EH
    Nat Med; 1999 Jun; 5(6):601-4. PubMed ID: 10371488
    [No Abstract]   [Full Text] [Related]  

  • 35. NOD mice and autoimmunity.
    Aoki CA; Borchers AT; Ridgway WM; Keen CL; Ansari AA; Gershwin ME
    Autoimmun Rev; 2005 Jul; 4(6):373-9. PubMed ID: 16081028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells.
    Haase C; Yu L; Eisenbarth G; Markholst H
    Clin Exp Immunol; 2010 Jun; 160(3):331-9. PubMed ID: 20180832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cell immunotherapy for autoimmune diabetes.
    Feili-Hariri M; Flores RR; Vasquez AC; Morel PA
    Immunol Res; 2006; 36(1-3):167-73. PubMed ID: 17337777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin2 gene (Ins2) transcription by NOD bone marrow-derived cells does not influence autoimmune diabetes development in NOD-Ins2 knockout mice.
    Martin-Pagola A; Pileggi A; Zahr E; Vendrame F; Damaris Molano R; Snowhite I; Ricordi C; Eisenbarth GS; Nakayama M; Pugliese A
    Scand J Immunol; 2009 Nov; 70(5):439-46. PubMed ID: 19874548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment.
    Hotta-Iwamura C; Tarbell KV
    J Leukoc Biol; 2016 Jul; 100(1):65-80. PubMed ID: 26792821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-antigen expression in the peripheral immune system: roles in self-tolerance and type 1 diabetes pathogenesis.
    Fuhlbrigge R; Yip L
    Curr Diab Rep; 2014; 14(9):525. PubMed ID: 25030265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.